MedMira Inc.
MMIRF · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Revenue | $51 | $59 | $69 | $62 |
| % Growth | -14.3% | -14.3% | 11.8% | – |
| Cost of Goods Sold | $19 | $16 | $23 | $9 |
| Gross Profit | $31 | $43 | $46 | $53 |
| % Margin | 62% | 72.8% | 66.1% | 85.5% |
| R&D Expenses | $118 | $265 | $459 | $423 |
| G&A Expenses | $303 | $237 | $385 | $342 |
| SG&A Expenses | $167 | $315 | $476 | $454 |
| Sales & Mktg Exp. | $57 | $78 | $92 | $112 |
| Other Operating Expenses | $0 | $192 | $206 | $234 |
| Operating Expenses | $285 | $773 | $1,141 | $1,111 |
| Operating Income | -$472 | -$730 | -$1,096 | -$1,059 |
| % Margin | -930.7% | -1,234.4% | -1,588.2% | -1,714.9% |
| Other Income/Exp. Net | -$335 | -$254 | -$104 | -$242 |
| Pre-Tax Income | -$1,041 | -$983 | -$1,200 | -$1,301 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$751 | -$983 | -$1,200 | -$1,301 |
| % Margin | -1,482.2% | -1,663.5% | -1,739% | -2,107.1% |
| EPS | -0.001 | -0.001 | -0.002 | -0.002 |
| % Growth | -10% | 41.2% | 10.5% | – |
| EPS Diluted | -0.001 | -0.001 | -0.002 | -0.002 |
| Weighted Avg Shares Out | 697,666 | 701,731 | 701,731 | 697,666 |
| Weighted Avg Shares Out Dil | 697,666 | 701,731 | 701,731 | 697,666 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $242 | $254 | $245 | $242 |
| Depreciation & Amortization | $56 | $80 | $80 | $80 |
| EBITDA | -$453 | -$650 | -$875 | -$978 |
| % Margin | -893.8% | -1,099% | -1,267.7% | -1,585.3% |